Escherichia coli causes about 90% of urinary tract infections (UTI), and more than 95% of all UTI-causing E. coli express type 1 fimbriae. The fimbrial tip-positioned adhesive protein FimH utilizes a shear forceenhanced, so-called catch-bond mechanism of interaction with its receptor, mannose, where the lectin domain of FimH shifts from a low-to a high-affinity conformation upon separation from the anchoring pilin domain. Here, we show that immunization with the lectin domain induces antibodies that exclusively or predominantly recognize only the high-affinity conformation. In the lectin domain, we identified four high-affinity-specific epitopes, all positioned away from the mannose-binding pocket, which are recognized by 20 separate clones of monoclonal antibody. None of the monoclonal or polyclonal antibodies against the lectin domain inhibited the adhesive function. On the contrary, the antibodies enhanced FimH-mediated binding to mannosylated ligands and increased by severalfold bacterial adhesion to urothelial cells. Furthermore, by natural conversion from the high-to the low-affinity state, FimH adhesin was able to shed the antibodies bound to it. When whole fimbriae were used, the antifimbrial immune serum that contained a significant amount of antibodies against the lectin domain of FimH was also able to enhance FimH-mediated binding. Thus, bacterial adhesins (or other surface antigens) with the ability to switch between alternative conformations have the potential to induce a conformation-specific immune response that has a function-enhancing rather than -inhibiting impact on the protein. These observations have implications for the development of adhesin-specific vaccines and may serve as a paradigm for antibody-mediated enhancement of pathogen binding.
Bacterial adhesion is the first step in the successful establishment of infection by pathogens, and bacterial adhesins have for a long time been prime candidates as targets for antibacterial therapeutics such as specific-ligand-like inhibitors and vaccines. Type 1 fimbriae of Escherichia coli are filamentous appendages that confer bacterial binding to glycoproteins with terminally exposed mannose (9) . The type 1 fimbrial adhesin is expressed by more than 90% of uropathogenic strains of E. coli and has been demonstrated to be crucial for the establishment of urinary tract infections (UTIs) in mice (18, 47) . Its role in establishing infection in humans is less clear (6, 14) . Here, we show that the adhesin's capability to dynamically switch between alternative conformations significantly affects its antigenic properties and the functional impact of the antibody binding.
Type 1 fimbriae are 0.5-to 1.5-m-long structures that are assembled via the chaperone-usher pathway. Mannose-specific binding is mediated by a 30-kDa adhesive protein, FimH, localized in a fimbrial tip structure which also includes the minor subunits FimG and FimF and is attached to the fimbrial rod composed of the polymerized major protein, FimA. FimH consists of two domains connected by a short linker chain: the lectin domain (LD), with the mannose-binding pocket on its distal end, and the pilin domain (PD), connecting FimH to FimG (11, 27) . Both domains have Ig-like ␤-sandwich folds. Unlike the pilin subunit FimA, which is structurally highly variable, the primary structure of the adhesin FimH is 99% conserved (49) .
It was found recently that FimH can exist in two alternative conformations, with LD and PD either separated or closely interacting with one another (27) . When the domains interact, the LD assumes a more twisted, compressed conformation. The conformational change in LD has a profound functional impact. In the interacting-domain conformation, the mannosebinding pocket is rather open (loose), while in the separateddomain conformation, the mannose-binding pocket closes (Fig.  1) . As a result, the affinity for mannose of the interacting-domain conformation is much lower than that of the separated-domain conformation (K D [equilibrium dissociation constant] Х 300 ϫ 10 Ϫ6 M versus K D ϳ 1.2 ϫ 10 Ϫ6 M, respectively) (1) . Because the association of PD with LD affects the mannose-binding pocket located on the opposite part of LD, such regulation of FimH affinity is allosteric. As allosteric regulation is reciprocal in nature, binding of the ligand to the loose pocket in the interacting-domain, twisted conformation of LD facilitates the tightening of the binding pocket as well as untwisting of LD and separation of the domains. Thus, under equilibrium conditions and in the absence of the mannose ligand, the conformation of LD is heavily shifted toward the low-affinity, interacting-domain state (LAS). In contrast, under equilibrium conditions in the presence of mannose (soluble or surface attached), there is a shift in the conformation of LD toward the high-affinity, separated-domain state (HAS).
The allosteric properties of the FimH adhesin are the basis of shear-enhanced adhesion of E. coli mediated by type 1 fimbriae. Indeed, it has been shown that FimH-expressing bacteria bind to mannosylated surfaces much more strongly under flow-induced shear than under static conditions (40) . Singlemolecule force spectrometry experiments have also demonstrated that the application of a sufficient level of tensile mechanical force shifts FimH from a weakly to a strongly binding mode to mannose (51) . The structural basis of shear-enhanced and mechanically enhanced adhesion is the same-FimH domains are separated and sustained in this conformation under tensile force, thus switching LAS to HAS and preventing the latter from shifting back. Such force-enhanced or so-called catch-bond properties of FimH could be relatively widespread, as they have been observed in other bacterial adhesins (e.g., P and CFA/I fimbriae), as well as in eukaryotic adhesive proteins, such as P-/L-selectins, von Willebrand factor, and integrins (for a review, see reference 36). While extensive studies have focused on comparing the adhesive properties of different conformational states of FimH or LD and on deciphering the role of mechanical force in the modulation of FimH function, the effects of the conformational changes in LD on the immune response to fimbrial antigens has not been investigated. We have previously described a monoclonal antibody, MAb21, raised against purified LD, that has been shown to recognize a discontinuous (conformational) epitope in the HAS but not LAS conformation of the domain (27, 37) . However, the extent to which the alternative conformations of the adhesin affect its immunogenicity in general has not been investigated. Considering that FimH has been a major candidate for the development of a vaccine against uropathogenic E. coli, such an investigation would have significant value for the development of preventive and therapeutic strategies for UTI.
In this study, we examined multiple polyclonal antibody (PAb) and monoclonal antibody preparations raised against LD of FimH and determined that the immune response is heavily skewed toward antibodies specific against only the HAS conformation of FimH. Such antibodies, instead of inhibiting FimH function, significantly enhance its adhesive properties. This raises an important issue for understanding the physiological impact of the immune response against adhesins and other proteins that have the ability to dynamically shift their conformations.
MATERIALS AND METHODS

Strains.
The recombinant strains utilized here were described previously (35) . The allele encoding the FimH:wt (wild-type) variant was derived from E. coli MG1655 and is identical to the allele encoding FimH in E. coli J96 that was used to determine the X-ray crystallographic structure (11) . For more details, see Methods in the supplemental material.
Site-directed mutagenesis of fimH. Mutations were introduced into the fimH gene on the pGB2-24 plasmid by site-directed mutagenesis using the QuikChange kit as directed by the manufacturer (Stratagene, La Jolla, CA). Constructs containing the mutations were identified by sequencing the fimH gene.
Antibodies. The lectin domain of FimH:wt (amino acids 1 to 160) was used to raise 14 mouse polyclonal antisera, 6 rabbit polyclonal antisera, and 20 mouse monoclonal antibodies. Monoclonal antibody clones were selected as follows: multiple samples of hybridoma culture medium were sent to us by the provider and were tested in enzyme-linked immunosorbent assay (ELISA) for binding to immobilized LD both in the absence and in the presence of antibodies. Polyclonal antiserum was obtained from all animals that were immunized. Polyclonal rabbit anti-FimHt serum raised against a naturally occurring mannose-binding truncate FimH (25) was kindly provided by Scott Hultgren (Washington University, St. Louis, MO). For more details, see Methods in the supplemental material.
Protein purification. Fimbriae were purified from recombinant E. coli strains expressing type 1 fimbriae with different FimH proteins as described previously (37) . Lectin domain (FimH LD) expression and purification was performed as described previously (1) .
Antibody testing. Antibody binding to FimH was measured in ELISAs as described previously (37) and in Methods in the supplemental material. MAbs and PAbs were screened for differential binding to immobilized fimbriae (0.4 mg/ml) or LD (0.05 mg/ml) in the absence or presence of 1% ␣-methyl-Dmannopyranoside (hereinafter termed mannose) in ELISAs. Determination of the H/LR (HAS-to-LAS ratio) was performed by ELISA as well. Mapping of epitopes for monoclonal antibodies was performed by ELISA as described previously (37) . The results of epitope scanning are summarized in Table S2 and Fig.  S4 in the supplemental material. Horseradish peroxidase (HRP) binding to fimbriae in the absence and presence of antibodies was measured for all monoclonal and all rabbit polyclonal antibodies as described previously (37) . For more details, see Methods in the supplemental material.
Adhesion assays. Bacterial strains at an A 600 of 0.3 were allowed to adhere to confluent monolayers of T24 human bladder epithelial cells (ATCC HTB-4) for 2 h at 37°C under 5% CO 2 as described previously (23, 45) in the absence or presence of 5 to 10 g/ml of purified antibodies or Fab fragments or 1% mannose. Adhesion was evaluated by light microscopy of stained slides, counting the numbers of bacteria and T24 cells in 10 to 20 fields of view and calculating the average number of bound bacteria per cell. For details, see Methods in the supplemental material.
Protein structure analysis. Analysis of the spatial distribution of epitope residues on FimH LD (1TR7.pdb) and FimHGFFC tip (3JWN.pdb) was performed using PyMol software (DeLano Scientific LLC, San Francisco, CA). The structures were aligned using reference positions 36, 74, and 127 as described previously (27) . The measurement of the root mean square deviation (RMSD) differences of MAb epitopes is described in detail in the supplemental material under "Measuring RMSD differences of MAb epitope." Briefly, the two instances of FimH low-affinity structures are compared with 12 instances of FimH high-affinity structures in VMD (Visual Molecular Dynamics software) to measure the RMSD of C␣ atoms of all epitope residues for each MAb group. The RMSD is calculated for each LAS versus each HAS structure, as well for each pair of structures that are either both HAS or both LAS to calculate the "between-state" and "within-state" RMSD.
RESULTS
Polyclonal antiserum raised against isolated LD is primarily HAS specific. Rabbit polyclonal antiserum PAb280 raised against LD was evaluated for the ability to recognize HAS versus LAS conformations by analyzing graded dose-response curves of the antiserum in ELISAs. We employed purified type 1 fimbriae immobilized on the plastic surface as the antigen. In fimbriae in the absence of mannose, FimH is in the native LAS conformation, characterized by LD docked to PD. The HAS can be induced in fimbrial FimH by the addition of soluble mannose. Thus, we compared antiserum binding in the absence and presence of 1% ␣-methyl-D-mannopyranoside (hereinafter termed mannose). In the absence of mannose, the effective dilution of the antisera for half-maximal binding (50% effective dose [ED 50 ]) was ϳ1:1,400, whereas in the presence of mannose, the ED 50 was ϳ1:7,400 ( Fig. 2A and Table 1 ), suggesting that the polyclonal antibodies recognize HAS more than 5 times better than LAS (HAS-/LAS-binding Ratio [H/LR] ϭ 5.4). The binding of the preimmune antiserum to fimbriae was very low and not affected by mannose (data not shown).
MAb21, a monoclonal antibody against purified LD specific for the high-affinity state of FimH (37) , displayed a binding pattern to fimbriae similar to that of the PAb280 antiserum. MAb21 bound much better to fimbriae in the presence of mannose than in its absence ( . Each data point represents the average of triplicate repeats. Data were fitted in GraphPad software to a sigmoidal dose-response curve with variable slope. The half-maximal dilution (ED 50 ) was determined both in the absence and in the presence of mannose to calculate the HAS-to-LAS ratio (H/LR). PAb280 and MAb21 titrations were simultaneously carried out on immobilized LD to determine the ED 50 values and H/LRs (see Table S1 in the supplemental material). OD 650 nm, optical density at 650 nm. 50 values of polyclonal antisera recognizing isolated LD in the absence and the presence of mannose were determined as described in Materials and Methods.
b The high-versus low-affinity-state ratio (H/LR) was calculated for each serum or MAb as the ratio of the ED 50 in the presence versus the ED 50 in the absence of mannose. The H/LR was significantly greater than 1.0 unless indicated otherwise. NS, not significant.
c P ϭ 0.29.
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cess of nonspecific immunoglobulins did not have any effect on the binding of polyclonal anti-FimH antiserum (PAb280) to FimH (see Fig. S1 in the supplemental material). In contrast to the binding to fimbriae, the presence of mannose did not increase (and actually slightly inhibited; see Table  S1 in the supplemental material) the binding of both MAb21 and PAb280 to purified LD, which is sustained in the HAS conformation with or without mannose because of the absence of PD (1, 27, 37) .
Furthermore, we tested 7 mouse and 4 additional rabbit polyclonal antisera raised against purified LD for the ability to differentially recognize purified fimbriae in the presence and absence of soluble mannose. The antisera were obtained using different commercial suppliers and different batches of purified LD. All antisera recognized purified LD similarly with or without mannose, again with slight inhibition of antibody binding by mannose (see Table S1 in the supplemental material). At the same time, all but one of the anti-LD sera recognized the mannose-induced HAS conformation of the fimbrial FimH significantly better than the LAS conformation, with H/LRs ranging from 2.01 to 17.67 (Table 1 ). Though there was over 100-fold variability in the absolute strength of the antibody responses of the different sera, no correlation between H/LR and titer level was observed (see Fig. S2 in the supplemental material). The only serum sample with no significant difference in binding with or without mannose was rabbit antiserum PAb33, whose H/LR was 1.39. Similarly, fimbrial binding of antibodies raised against purified PD also was not affected by mannose (Table 1) .
Thus, a strong HAS-specific antibody response is induced upon immunization with purified LD of FimH.
All monoclonal antibodies raised against LD are HAS specific. We obtained 20 monoclonal antibodies (MAbs) raised against purified LD and derived from six different mice. All MAbs recognized purified LD equally well in the absence or presence of mannose (see Fig. S3A in the supplemental material). At the same time, all MAbs recognized fimbrial FimH much better in the presence of mannose (Table 2 ; also see Fig.  S3B in the supplemental material). Though the original titers of some MAbs were too low to reach saturation level, for those antibodies that were of sufficiently high concentration, the H/LRs ranged from 13.0 to 390.0 (Table 2 ; also see Fig. S3C in the supplemental material). Thus, all of the MAbs obtained appeared to be specific for the HAS conformation of LD.
We tested the antibodies on a panel of fimbriae with various mutations in LD to identify epitopes (see Fig. S4 and Table S2 in the supplemental material). We found that the MAbs fell into four groups based on the locations of structural mutations in FimH that severely diminished antibody binding.
The group A antibodies, which include 8 antibody clones (Table 2) , recognize an epitope comprised of residues 26, 29, and 153 to 157 (Fig. 3A , low-affinity state, and B, high-affinity state). This epitope is also recognized by the previously characterized MAb21 clone and is positioned at the bottom of the beta-barrel-shaped LD facing the pilin domain, with most of the epitope buried in the interdomain interface (Fig. 3, darker  residues) . Thus, the group A epitope is far distant from mannose-binding-site residues (Fig. 3, yellow) . This epitope has distinctly different conformations in the high-and low-affinity states of LD, with the between-state C␣ atoms root mean square deviation (C␣ RMSD) being 3.25 Å, which is significantly higher than the within-state C␣ RMSD of 0.26 Å, based on comparison of available structures of alternative FimH conformations. The H/LRs for group A antibodies ranged from 31 to 308.
The group B antibodies (5 clones) recognize an epitope that includes residues 59, 60, 88, 132, 141, and 143 ( Fig. 3C and D) . This epitope is located mostly on the side of the LD beta-barrel that does not overlap with the interdomain interface. It is relatively close to the mannose-binding site, though it does not share any residues with the latter. The between-state C␣ RMSD is 0.82 Å, versus 0.21 Å for the within-state C␣ RMSD value. The H/LRs of the group B epitope antibodies ranged from 13 to 94.
The group C antibodies (6 clones) recognize an epitope partially overlapping with the group B epitope, sharing residues 59, 60, 141, and 143 but not 88 and 132 and having, in addition, residues 57, 62, 89, 130, and 145 ( Fig. 3E and F) . Like the group B epitope, the group C epitope is relatively close to but does not overlap the mannose-binding site. The inter-state C␣ RMSD is 1.42 Å, versus the within-state C␣ RMSD of 0.24 Å. The H/LRs of the group C epitope ranged from 149 to 386.
Finally, group D is represented by only one antibody clone (MAb34) that recognizes an epitope including residues 55, 78, 91, 92, and 93 ( Fig. 3G and H) . The epitope is located on the side of the LD beta-barrel, relatively distant from both the interdomain interface and the mannose-binding site. It has a relatively low but still significant difference in the inter-state versus the within-state C␣ RMSD (0.336 Å versus 0.177 Å, respectively; P ϭ 0.0007). The H/LR of MAb34 is 244.
Thus, we have indentified the presence of at least 4 distinct 3-dimensional conformational epitopes specific for the highaffinity form of LD. None of the epitopes overlapped with the mannose-binding pocket of LD, and only the group A epitope overlapped with the interface between LD and PD.
Antibodies raised against LD do not inhibit but rather increase mannose-specific binding. None of the MAbs interfered with the mannose-specific binding of HRP to isolated LD immobilized on plastic surfaces (see Fig. S5A in the supplemental material). However, all MAbs increased to various degrees the mannose-specific HRP binding to fimbria-incorporated FimH (Fig. 4A) . The strongest increase in the binding was mediated by the group A epitope-specific antibodies.
Similar to MAbs, out of all polyclonal rabbit antisera, none inhibited HRP binding to isolated LD (see Fig. S5B in the supplemental material), including antisera with a predominant response against the high-affinity state (PAb280, H/LR 5.4) or with no significant differences in the ability to recognize HAS over LAS (PAb33). When HRP binding to fimbrial FimH was tested, a binding increase was noted for all antisera with an . Only PAb33, which showed no preferential recognition of the high-affinity state of LD, had no detectable effect on HRP binding by fimbriae (Fig. 4B) . We also tested E. coli adhesion to a monolayer of T24 urinary bladder epithelial cells in the presence and absence of polyclonal antisera (PAb280 and PAb33) and MAb21 antibodies. PAb280 enhanced bacterial adherence to T24 uroepithelial cells, as did MAb21, both in a mannose-inhibitable manner (Fig. 4C) . Furthermore, bacterial cell adhesion was enhanced by purified Fab fragments of PAb280. In contrast, PAb280 preimmune antiserum did not affect bacterial adhesion. Polyclonal antiserum PAb33 that does not have a measurable pool of high-affinity-specific antibodies also failed to enhance bacterial adherence, although it did not inhibit the bacterial adherence either.
Thus, none of the antibodies raised against LD demonstrate a notable inhibitory property against the mannose-specific binding of LD. In contrast, most of the antibodies substantially increase the binding property of FimH, including adhesion to uroepithelium.
Antibodies raised against whole fimbriae enhance FimHmediated binding. We immunized two rabbits with purified whole fimbriae. Both immune antisera were able to recognize whole fimbriae (Fig. 5A) , although the response from one rabbit (PAb49) appeared to be stronger than the response from the other one (PAb50). PAb50, however, was able to efficiently recognize isolated LD as well, unlike PAb49.
When both antisera were tested for the ability to influence the FimH-mediated binding of soluble HRP, PAb50 but not PAb49 significantly increased the binding (Fig. 5B) , i.e., it had an effect similar to that of the anti-LD antibodies described above.
Thus, the immune response toward whole type 1 fimbriae can elicit significant levels of anti-LD antibodies that have an enhancing effect on FimH binding.
FimH can shed the bound HAS-specific antibody. We determined whether the conditions favoring a shift from HAS to LAS would facilitate removal of the antibodies bound to LD in the HAS conformation. Various MAbs were bound to fimbrial FimH in the presence of mannose, and the unbound fraction was removed by washing. Then, a buffer with or without soluble mannose was added, followed by additional washes after different periods of time and measurement of the MAb fraction remaining bound to FimH. All of the tested antibodies were shed from fimbrial FimH at a significantly higher rate upon the removal of mannose than in the presence of mannose (Fig. 6 , open symbols), resulting in a more than 50% loss in the case of C and D epitope-specific antibodies (MAb29 and MAb34, respectively) in 15 min. A B epitope-specific antibody (MAb25) required more than 60 min for 50% loss. The complex with an A epitope antibody (MAb21) was relatively stable but also dropped almost 30% after 2 h upon the removal of mannose. In contrast, the amount of antibodies bound to isolated LD remained the same both in the presence and in the absence of mannose (Fig. 6, closed symbols) .
Thus, the removal of mannose from FimH results in "shedding" of the antibodies bound to the HAS conformation of LD. 
DISCUSSION
Taken together, the data presented here show that immunization with the mannose-binding domain of the FimH adhesin induces antibodies that predominantly (i) recognize only the high-affinity domain conformation assumed upon separation from the pilin domain; (ii) increase FimH-mediated adhesion rather than inhibiting it; and (iii) can be shed from FimH upon conformation shift. These observations reveal complex structural and functional dynamics of the antigen-antibody interaction when the antigen can switch between alternative conformations.
Most antigenic epitopes in proteins are conformational (discontinuous, or 3-dimensional) in nature (46) , and there are a large number of examples where MAbs recognize one conformation of a protein and not the other (3, 4, 21, 26) . Thus, it was expected that upon immunization with purified LD (which is in a stable HAS conformation), a portion of the response would be HAS specific. It was surprising, however, that in almost all samples of polyclonal antisera, the level of antibody binding to the mannose-induced HAS conformation of FimH was so predominant. The high binding of antibodies to fimbrial FimH in the presence of mannose is unlikely to be due to antibody recognizing mannose in the pocket as a hapten, since the addition of mannose does not increase antibody binding to immobilized LD, which would be expected if this were the case. It is not likely to be due to a relatively high avidity of HAS-specific antibodies either but, rather, is likely to be due to the large pool of HAS-specific antibodies in the antisera. Indeed, all 20 hybridoma clones obtained against isolated LD were HAS specific. Mapping of the HAS-specific epitopes for the monoclonal antibodies confirmed that they are ligand-induced binding sites (LIBS), since all four of them are located away from the mannose-binding pocket and have, to various extents, different conformations in the HAS and LAS forms of LD. Since most MAbs which recognized the same group epitope had different H/LRs (meaning different concentrations of mannose required to induce clone-specific LIBS), they most likely belong to distinct clones rather than to the same clone. Multiple origins of monoclonal antibodies recognizing overlapping discontinuous epitopes have been described previously (17) .
While the H/LRs for polyclonal antisera were generally well above 1, all of them could also recognize fimbrial FimH in the absence of mannose relatively well, especially in comparison with the monoclonal antibodies. This indicates that besides HAS-specific antibodies, the antisera contained antibodies which could bind to the LAS conformation, i.e., they were specific to common epitopes. In any case, HAS-specific and common antibodies failed to inhibit the mannose-specific interaction between LD and HRP when tested, even at increasingly high concentrations. Evidently none of the protein regions (linear or conformational) of the mannosebinding pocket of LD were sufficiently immunogenic to elicit strong and/or high-affinity immune responses. Another explanation for the absence of antibodies against the binding site of FimH which would be able to inhibit binding is the possibility that upon being injected into the animal, FimH antigen binds to bulky glycoproteins in the host which sterically prevent the production of antibodies against this part of the protein. To investigate this hypothesis, a similar study should be conducted, using for immunization FimH where either the binding pocket is inactivated by point mutation (that presumably does not affect the epitope formation) or the binding pocket is blocked by a small, tightly attached ligand.
The observations that the anti-LD immune response does not elicit binding-inhibitory antibodies conflict with the results of previous studies where type 1 fimbriae-mediated adhesion of bacteria was inhibited by anti-FimH antibodies (24, 25, 30, 39, 43, 44) . One possible explanation could be differences in the immunization or antigen preparation protocols. However, in addition to our own preparations of anti-LD antibodies, we also examined antiserum obtained by another laboratory and used in previous studies (anti-FimHt, a generous gift of Scott Hultgren, Washington University, St. Louis) (25) . FimHt is a naturally occurring N-terminally truncated FimH protein which is functionally active and contains the entire LD (19, 25) . Thus, FimHt is likely to be in the HAS conformation, and indeed, the anti-FimHt antiserum has a significant pool of anti-HAS antibodies and is able to increase FimH-mediated binding of HRP similarly to other anti-LD antiserum samples. We did not test antisera against the FimH/FimC complex which also have been proposed to exhibit FimH inhibitory activity (24, 30) . However, in the FimH/FimC complex, LD is also in the HAS conformation, identical to isolated LD (likely due to the domain separation caused by FimC wedging).
Another reason for the apparent discrepancies of our binding inhibition studies with previously published reports could be differences in the test conditions. In our study, we probed the function of purified LD or fimbriae that are immobilized on a plastic surface under nonsaturating conditions. In contrast, in the inhibition experiments described previously, a suspension of type 1 fimbriae-expressing bacteria was mixed with antibodies and the mixture was added directly to the target cells or mannosylated receptors (24, 25, 30, 43) . Under the latter conditions, an apparent binding inhibition effect could be caused by clumping of either the bacterium-expressed fimbriae or the whole bacteria. When we conducted inhibition experiments under a similar experimental setup, we observed a de- crease in the number of bound bacteria in the presence of all antibodies tested when high concentrations were used, including antisera raised against whole fimbriae and purified pilin domain (not shown). Closer inspection revealed that microaggregates of bacterial cells formed under these conditions and were removed easily during the washing step in adhesion assays, reducing the number of bacteria remaining attached. However, when we used purified Fab fragments instead of whole antibodies, we never observed any inhibition (or aggregation) under even the highest concentration used. Thus, under certain conditions, an apparent adhesion inhibition effect could be due to nonspecific effects rather than direct blockage of the binding pocket. However, the actual basis for discrepancies between our inhibition studies and those of others remains to be determined. All but one of the anti-LD antibody samples led to functional activation of fimbria-incorporated FimH by increasing the mannose-specific binding of soluble HRP. This counterintuitive effect was shown previously with MAb21 antibodies (37) . In the present study, we also show that both monoclonal and polyclonal antibodies significantly increase the number of bacteria adhering to uroepithelial cells. Importantly, the adhesion enhancement effect was seen with Fab fragments and at relatively low concentrations of whole antibodies, where no bacterial aggregation could be noted. Such antibody concentrations are likely to be more relevant to the natural immune response to infection or even vaccine administration.
Antibodies able to stabilize a protein in one conformation, increasing its affinity toward the ligand, have been described previously for several proteins, including integrins (4, 12) , von Willebrand factor (42), mouse macrophage galactose/N-acetylgalactosamine-specific calcium-type lectin (mMGL) (21) , and rhodopsin (3). We have previously proposed that the enhancement of mannose binding by the MAb21 antibody is due to its wedged position between the domains (like the FimC chaperone in FimH/FimC complex). Based on the recently elucidated crystal structure of the domain-docked LAS conformation of LD, the MAb21-specific A epitope indeed overlaps with the interdomain interface, though the domains interact rather differently from what was computationally predicted previously (27) . However, the three other LIBS epitopes identified here are positioned away from the interdomain interface, and antibody binding at these sites is unlikely to result in steric interference with domain interaction (i.e., interdomain wedging). Thus, HAS-specific monoclonal and polyclonal antibodies are likely to be able to sustain the HAS conformation, at least in part, by stabilizing the HAS-specific conformation of LIBS epitopes.
The described effect of anti-FimH LD antibodies increasing bacterial adhesion raises the question of whether such immune responses could promote bacterial infection rather than provide protection. In the last decade, there has been a rising number of reports describing antibodies which actually enhance viral or bacterial infection and pathogenesis (5, 7, 16, 28) . One mechanism of this antibody-dependent enhancement (so-called ADE phenomenon) is based on the bound antibody interacting with the receptor on host cells directly or through intermediary molecules, like complement components (5, 7, 16) . Another mechanism of ADE is based on antibody binding to microbial antigens that results in sequestering important targets from the immune defense mechanisms (28) . Here, we describe an additional mechanism for possible enhancement of pathogenesis via enhancement of adhesin function.
One should consider, however, that antibody-mediated enhancement of microbial adhesion may not necessarily lead to increased infection. An increased binding of bacteria to target cells could lead to increased protection of the host (7). For example, FimH-mediated binding of E. coli and other enterobacteria to the GP2 receptor of M cells is considered to be a prerequisite for the mucosal immune response against these bacteria (15) . Also, FimH locked in the HAS conformation is much more sensitive to inhibition by solubilized mannosylated compounds than FimH able to switch between LAS and HAS (31) . Therefore, the effect of "activating" antibodies on the course of bacterial colonization could potentially be advantageous for clearing the organism from bacterial infection. Indeed, a protective effect against bladder infection by E. coli was reported for immunization with FimHt and FimH/FimC in murine models and, partially, in a primate model (8, 24, 25, 33) . However, using these antigens has not led to the development of a vaccine for clinical application. Thus, it would be important to determine the exact mechanism by which protection may have occurred in the animal infection models.
One important issue in this regard is to consider which FimH variant is expressed by the strain used for animal protection studies. A large portion of uropathogenic strains, especially those causing cystitis or asymptomatic bacteriuria, express FimH that, under equilibrium conditions, is predominantly in the LAS conformation. On the other hand, it has been shown that naturally occurring mutations in FimH can increase receptor binding under static conditions by promoting the HAS conformation via interference with the domain-domain interaction or other allosteric effects on the LD structure (1, 37). These FimH mutations were shown to be positively selected in some urinary tract isolates (predominantly those that cause kidney infection), possibly to increase cell tropism under the low-shear conditions of urinary tract compartments above the urethra (34, 48) . However, the increased predominance of the HAS conformation in FimH mutants might represent a liability for E. coli in vaccinated animal hosts. Thus, immunization with FimH constructs in the HAS conformation could have different protective effects against bacteria expressing different natural variants of FimH.
It will be interesting to determine functional as well as protective effects of antibodies obtained against the LAS conformation of LD. One should consider, however, that unlike the HAS conformation that is stable in purified LD or the FimH/ FimC complex, the native LAS conformation only exists when domains are docked. It could be readily shifted into the HAS conformation by binding of a mannosylated ligand, partial enzymatic degradation of FimH, or tensile mechanical force of any origin. It is likely that, similar to the HAS-specific epitopes, putative LAS-specific epitopes are primarily or exclusively of a conformational rather than linear nature. The immune response to conformational epitopes involves direct interaction of the entire antigen molecule with B cells. It is unclear whether the LAS conformation is stable enough to be preserved as such during the close B-cell interaction with the fimbrial tip-associated FimH.
The results of the experiment with antiserum raised against whole fimbriae hint that the above-described scenario might well be true. In this instance, two antifimbrial sera differ in their ability to recognize isolated LD, which correlates with their ability to enhance FimH-mediated binding. We have previously determined that FimH in the fimbria used for immunization is in the LAS conformation (in the absence of mannose or shear) (27) . Thus, it is possible that for immunization, one would need to obtain either purified LD or whole FimH protein where the LAS conformation is stabilized by, for example, the introduction of disulfide bonds as reported previously (27) . Such studies are under way. Dynamic interplay between the two alternative conformations of FimH could have a significant role for the adaptive immune response during natural E. coli infections. It is necessary to evaluate what type of antibody response is naturally elicited against FimH and how it affects E. coli pathogenesis. From these perspectives, the ability of FimH to shed antibodies bound to LD could be physiologically significant. It is expected that transient binding and unbinding of natural mannosylated ligands (e.g., soluble or cell surface glycoproteins) to the fimbrial FimH would result in a dynamic shifting between FimH conformations. This phenomenon could hypothetically work both ways under physiological conditions, i.e., LAS can switch to HAS and HAS to LAS. Continuous shifting back and forth between the conformational states of LD could cause repeated shedding by LD of antibodies specific to either HAS or LAS conformations. This in turn could affect, for example, opsonic or functional effects of the anti-FimH antibodies, as well as the adaptive immune response itself. Whether or not antibody shedding happens in vivo and has a physiological impact, such as immune evasion, remains to be determined. Antibody shedding is a known phenomenon in parasitic nematodes that are able to slough off antibodies against their surface coat, but this involves complete shedding of the surface antigen and takes many hours of growth (10) . To our knowledge, our study is the first to report the phenomenon of antibody shedding mediated by a conformational switch of the protein antigen.
It has been hypothesized that force-enhanced, catch-bond properties are widespread among adhesive proteins of both prokaryotic and eukaryotic cells. For example, P-selectins (29), integrins (2, 22) , and Von Willebrand factor (20, 50) were shown to strengthen interactions with ligands under increased shear and mechanical tension. Shear-enhanced binding has been demonstrated for P fimbriae (32) and the CFA/I adhesin of E. coli (38) , as well as for Streptococcus gordonii. Like FimH, mechanical regulation of many of these adhesive proteins is known or suspected to involve allosteric changes in the protein (41) . Because conformational shift is an intrinsic feature of allosteric proteins, such adhesive proteins are likely to exist in alternative conformations against which specific antibody responses could be evoked. Indeed, antibodies specific to the "activated" integrin conformation are well characterized and there are many similarities of their functional effects with the HAS-specific FimH antibodies (37) . In addition to adhesive proteins, allosteric properties and/or shifts between alternative conformational states are attributes of many other types of proteins, such as enzymes, toxins, or transport molecules (13) . Thus, understanding the extent to which different conformations are capable of inducing specific immune responses and the functional impact of such responses will help us to better understand the molecular pathogenesis of diseases and to design more effective vaccines, antibody-based therapeutics, and diagnostics, as well as a variety of low-molecular-weight allosteric modulators of proteins that play crucial roles in sustaining health or in disease development.
